Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€1.38
28.06.21
€2.50
28.06.22
-71.16%
29.06.22

Aptose Biosciences

Start price
Target price
Perf. (%)
€3.26
12.06.21
€1.00
12.06.22
-14.11%
26.06.21

buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€3.22
11.06.21
€4.00
11.06.22
-69.57%
14.12.21

Could be worthwhile Investment >10% per year
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€4.64
01.05.21
€4.50
01.05.22
-30.60%
11.06.21

Could be worthwhile Investment >10% per year
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€5.50
24.03.21
€5.50
24.03.22
-15.64%
01.05.21

Could be worthwhile Investment >10% per year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€11.99
15.01.21
-
4.50%
05.02.21

Risky Investment
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.75
19.11.20
€2.90
19.11.21
-11.05%
10.07.21

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€60.55
16.11.20
€105.00
16.11.21
-10.40%
28.11.20

Could be worthwhile Investment >10% per year
Good rating
Differentiated customer and product portfolio
Risky balance sheet
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.45
16.11.20
-
16.11.21
-14.81%
17.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€1.66
13.11.20
-
13.11.21
-33.13%
15.07.21

Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€54.95
13.11.20
-
13.11.21
-40.00%
15.07.21

Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€57.75
02.11.20
-
04.11.21
-4.85%
13.11.20

Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.25
29.10.20
-
04.11.21
79.39%
15.07.21

Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.53
28.10.20
€2.10
04.11.21
8.70%
19.11.20

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.65
22.10.20
-
29.10.20
-4.62%
29.10.20

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.76
13.10.20
€2.90
28.10.20
-8.43%
28.10.20

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Trillium Therapeutics

Start price
Target price
Perf. (%)
€11.70
02.10.20
-
04.11.21
-14.10%
10.12.20

Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€60.90
01.10.20
-
02.11.20
-5.17%
02.11.20

Trillium Therapeutics

Start price
Target price
Perf. (%)
€12.85
21.09.20
-
04.10.20
-7.39%
04.10.20

buy
Trillium Therapeutics

Start price
Target price
Perf. (%)
€14.00
21.09.20
-
04.11.21
9.18%
05.11.21

Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.10
15.09.20
-
22.10.20
-4.95%
22.10.20

Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€1.99
10.09.20
-
04.11.21
11.67%
15.07.21

Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€67.20
10.09.20
-
01.10.20
-9.38%
01.10.20

Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€2.14
08.09.20
-
04.11.21
-22.43%
13.11.20

Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.05
08.09.20
-
04.11.21
59.76%
05.11.21